Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer

Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2019.0280


Rapid advances in genome sequencing technologies

Prof. Dr. M Ebert, MD, PhD.


Over the past decade, substantial progress has been made from NGS primary tumor single biopsy to multiple tumoral and liquid biopsies. The evidence of extensive genetic and transcriptomic heterogeneity suggest the urgent need for the development of multiple agents as druggable biomarkers for the selection of most effective combination of drugs for every individual patient. Emerging validation trials on genomic and trasncriptomic analysis could provide potential clinical implications.

(Citation: Gastric & Breast Cancer 2019; 14(1) 22-27)

You can have an online full-text access and a PDF of this article:
  • Either purchase this paper for €35 EUR. Please, click here
Please specify DOI of article
  • Or through one year subscription PayPal

Online ISSN : 1109 - 7647
Print ISSN : 1109 - 7655

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We subscribe to the HONcode principles. Verify here.
please, read our policy about privacy and confidentiality of information and transparency of sponsorship

last update: 29 April 2019